Ben Van Baelen - Concepedia

Concepedia

Author

Ben Van Baelen

Janssen (Belgium)

Also Known As

Ben Van Baelen, Ben van Baelen, Van Baelen, Ben

19

Publications

1.6K

Citations

12

H-Index

13

Concepts

All Affiliations

Janssen (Belgium)Janssen (Netherlands)University of Cape Town Université Paris-Est Créteil Desmond Tutu HIV Foundation

BV

About

Ben Van Baelen is an author at Janssen (Belgium) specializing in medicine, virology, and immunodeficiencies.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	193
2	Public Health	1	1	15
3	Epidemiology	1	1	15
4	Immunology	1	1	15
5	Clinical Epidemiology	1	1	15

Ben Van Baelen

×

12

Publications

1.6K

Citations

12

H-Index

	Year	Citations
Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women Annaléne Nel, Neliëtte van Niekerk, Saidi Kapiga, New England Journal of Medicine	2016	454
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis Alexander S. Pym, Andreas H. Diacon, Shenjie Tang, European Respiratory Journal	2015	333
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections Graham R. Foster, Christophe Hézode, Jean–Pierre Bronowicki, Gastroenterology Genotype 3Viral PersistenceViral HepatitisTelaprevir AloneAntiviral Therapy	2011	178
Resistance Profile of Darunavir: Combined 24-Week Results from the POWER Trials Sandra De Meyer, Tony Vangeneugden, Ben Van Baelen, AIDS Research and Human Retroviruses	2008	157
Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients Richard Haubrich, Dan Berger, Philippe Chiliade, AIDS	2007	113
Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study Annaléne Nel, Neliëtte van Niekerk, Ben Van Baelen, The Lancet HIV	2021	95
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate Ramon Roozendaal, Jenny Hendriks, Thierry Van Effelterre, npj Vaccines	2020	69
Telaprevir-Related Dermatitis Jean‐Claude Roujeau, Maja Mockenhaupt, Steven R. Tahan, JAMA Dermatology	2012	60
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients Sandra De Meyer, Erkki Lathouwers, Inge Dierynck, AIDS	2009	58
Pharmacokinetics, safety and efficacy of darunavir/ritonavir in treatment-experienced children and adolescents Stéphane Blanche, Rosa Bologna, Pedro Cahn, AIDS	2009	51

Page 1